PROMETHEUS BIOSCIENCES INC (RXDX)
Institutional ownership reported to the SEC as of Q2 2023, across 10 quarters.
4
Reporting holders
$67.0M
Reported value
97.0%
Held as options
-192
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Maven Securities LTD | $65.0M | options only | 0.98% | new | OPTIONS |
| UBS ASSET MANAGEMENT AMERICAS INC | $2.0M | 18,448 | 0.00% | 4q | HELD |
| FinTrust Capital Advisors, LLC | $1.4K | 13 | 0.00% | 4q | HELD |
| SIMPLEX TRADING, LLC | $113 | options only | 0.00% | 7q | OPTIONS |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 4 | $67.0M | 18,461 | 2 | 0 | 0 | 97.0% |
| Q1 2023 | 196 | $3.9B | 34,675,420 | 35 | 76 | 61 | 3.5% |
| Q4 2022 | 193 | $4.0B | 32,636,284 | 81 | 59 | 40 | 10.0% |
| Q3 2022 | 149 | $2.0B | 32,853,339 | 50 | 49 | 25 | 4.0% |
| Q2 2022 | 116 | $885.0M | 30,808,471 | 32 | 34 | 35 | 1.7% |
| Q1 2022 | 103 | $1.1B | 27,660,134 | 30 | 26 | 28 | 0.5% |
| Q4 2021 | 81 | $1.1B | 28,747,693 | 32 | 35 | 4 | 0.9% |
| Q3 2021 | 51 | $573.2M | 24,292,943 | 6 | 17 | 14 | 0.0% |
| Q2 2021 | 49 | $667.0M | 27,487,007 | 22 | 10 | 10 | 0.0% |
| Q1 2021 | 41 | $425.7M | 24,245,109 | 41 | 0 | 0 | 0.0% |